{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10803758", "DateCompleted": {"Year": "2000", "Month": "07", "Day": "07"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0886-022X", "JournalIssue": {"Volume": "22", "Issue": "2", "PubDate": {"Year": "2000", "Month": "Mar"}}, "Title": "Renal failure", "ISOAbbreviation": "Ren Fail"}, "ArticleTitle": "The role of ginsenoside-Rd in cisplatin-induced acute renal failure.", "Pagination": {"StartPage": "115", "EndPage": "127", "MedlinePgn": "115-27"}, "Abstract": {"AbstractText": ["Ginsenoside-Rd has been proved to decrease the severity of renal injury induced by cisplatin, in which proximal urinaferous tubules represent the main site of injury. When ginsenoside-Rd was given orally at a dose of 1 or 5 mg/kg body weight/day for 30 consecutive days prior to cisplatin injection, the activities of the antioxidation enzymes superoxide dismutase and catalase were higher, while malondialdehyde levels in serum and renal tissue were lower in the treated rats than in the controls. The levels of urea nitrogen and creatinine in serum were decreased in rats given ginsenoside-Rd. Decreased urinary levels of glucose, sodium and potassium reflected a protective action against the renal dysfunction caused by cisplatin. In addition, it was demonstrated that ginsenoside-Rd affected cultured proximal tubule cells exposed to cisplatin."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Wakan-Yaku, Toyama Medical and Pharmaceutical University, Sugitani, Japan. yokozawa@ms.toyaxna-mpu.ac.jp"}], "Identifier": [], "LastName": "Yokozawa", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liu", "ForeName": "Z W", "Initials": "ZW"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Ren Fail", "NlmUniqueID": "8701128", "ISSNLinking": "0886-022X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "4Y8F71G49Q", "NameOfSubstance": "Malondialdehyde"}, {"RegistryNumber": "AYI8EX34EU", "NameOfSubstance": "Creatinine"}, {"RegistryNumber": "EC 1.1.1.27", "NameOfSubstance": "L-Lactate Dehydrogenase"}, {"RegistryNumber": "EC 1.11.1.6", "NameOfSubstance": "Catalase"}, {"RegistryNumber": "EC 1.11.1.9", "NameOfSubstance": "Glutathione Peroxidase"}, {"RegistryNumber": "EC 1.15.1.1", "NameOfSubstance": "Superoxide Dismutase"}, {"RegistryNumber": "Q20Q21Q62J", "NameOfSubstance": "Cisplatin"}, {"RegistryNumber": "WB232T95AV", "NameOfSubstance": "ginsenoside Rd"}], "MeshHeadingList": [{"QualifierName": ["chemically induced", "drug therapy", "enzymology", "pathology"], "DescriptorName": "Acute Kidney Injury"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["toxicity"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Blood Urea Nitrogen"}, {"QualifierName": ["metabolism"], "DescriptorName": "Catalase"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["toxicity"], "DescriptorName": "Cisplatin"}, {"QualifierName": ["blood"], "DescriptorName": "Creatinine"}, {"QualifierName": [], "DescriptorName": "Ginsenosides"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glutathione Peroxidase"}, {"QualifierName": ["drug effects", "enzymology", "pathology"], "DescriptorName": "Kidney Tubules, Proximal"}, {"QualifierName": ["metabolism"], "DescriptorName": "L-Lactate Dehydrogenase"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["metabolism"], "DescriptorName": "Malondialdehyde"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Panax"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Saponins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Superoxide Dismutase"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "5", "Day": "10", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "7", "Day": "15", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "5", "Day": "10", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10803758", "10.1081/jdi-100100858"]}}], "PubmedBookArticle": []}